{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:51:44Z","timestamp":1792741904079,"version":"4.5.0"},"reference-count":59,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2018,3,15]]},"abstract":"<jats:p>Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy. However, because ICIs block coinhibitory molecules on T cells and other immune cells, unleashing them to mediate tumor cell killing, they also can disrupt the maintenance of immunological tolerance to self\u2010antigens. Compared with chemotherapy, ICIs have a different toxicity profile, especially the occurrence of autoimmune\u2010like manifestations against multiple organ systems, including endocrine glands, commonly referred to as immune\u2010related adverse events. The aim of this review was to provide practical recommendations regarding the proper assessment and clinical management related to the new onset of endocrinopathies after the use of ICIs in patients with cancer. <jats:bold><jats:italic>Cancer<\/jats:italic> 2018;124:1111\u201021.<\/jats:bold> \u00a9 <jats:italic>2018 American Cancer Society<\/jats:italic>.<\/jats:p>","DOI":"10.1002\/cncr.31200","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T13:55:08Z","timestamp":1514987708000},"page":"1111-1121","source":"Crossref","is-referenced-by-count":105,"title":["Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management"],"prefix":"10.1002","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-9876","authenticated-orcid":false,"given":"Romualdo","family":"Barroso\u2010Sousa","sequence":"first","affiliation":[{"name":"Department of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Stephen","family":"Hodi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula B.","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Tolaney","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Min","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.045"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5256.1734"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.001"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1533209100"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.016"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.222"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3064"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.1.41"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01621"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.128"},{"key":"e_1_2_4_14_1","doi-asserted-by":"crossref","first-page":"3916395","DOI":"10.1155\/2017\/3916395","article-title":"General and specific genetic polymorphism of cytokines\u2010related gene in AITD","volume":"2017","author":"Xiaoheng C","year":"2017","journal-title":"Mediators Inflamm."},{"key":"e_1_2_4_15_1","first-page":"2087525","article-title":"Treatment of ipilimumab induced Graves' disease in a patient with metastatic melanoma","volume":"2016","author":"Azmat U","year":"2016","journal-title":"Case Rep Endocrinol."},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0833"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13297"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4560"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00448"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2300"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw640"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0562"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0208"},{"issue":"15","key":"e_1_2_4_24_1","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1200\/jco.2015.33.15_suppl.9050","article-title":"Association of immune\u2010related thyroid disorders with pembrolizumab (pembro, MK\u20103475) in patients (pts) with advanced melanoma treated in KEYNOTE\u2010001","volume":"33","author":"Robert C","year":"2015","journal-title":"J Clin Oncol."},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214603"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0146"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0213-x"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.55.0418"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1042-2"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0028"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30165-8"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3243"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30231-0"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611299"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008002"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.08.020"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2306"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2353"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0845"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13063"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.6750"},{"key":"e_1_2_4_42_1","volume-title":"Pembrolizumab [package insert]","author":"Merck and Company","year":"2016"},{"key":"e_1_2_4_43_1","unstructured":"Bristol\u2010Myers Squibb Company 2016 Bristol\u2010Myers Squibb Company Princeton NJ"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0499"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0671-4"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0011"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2118"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61684-0"},{"key":"e_1_2_4_50_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000443871","article-title":"From genetic predisposition to molecular mechanisms of autoimmune primary adrenal insufficiency","volume":"46","author":"Falorni A","year":"2016","journal-title":"Front Horm Res."},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-80-6-693"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30582-7"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089561"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022125"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.05.013"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1952"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2033-8"},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12119"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1140"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.31200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.31200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T18:32:20Z","timestamp":1760293940000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.31200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3,15]]}},"alternative-id":["10.1002\/cncr.31200"],"URL":"https:\/\/doi.org\/10.1002\/cncr.31200","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}